MARKET

SXTP

SXTP

60 degrees pharmaceuticals, Inc.
NASDAQ
0.5083
+0.0027
+0.53%
After Hours: 0.5001 -0.0082 -1.61% 19:47 12/31 EST
OPEN
0.5056
PREV CLOSE
0.5056
HIGH
0.5652
LOW
0.5019
VOLUME
679.69K
TURNOVER
--
52 WEEK HIGH
8.00
52 WEEK LOW
0.4500
MARKET CAP
2.15M
P/E (TTM)
-0.0883
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 12/30/2025 12:05
60 Degrees Pharmaceuticals Identifies Babesia Parasite In 24% Of Participants In Group Of 50 Patients With Chronic Fatigue
Benzinga · 12/29/2025 13:11
60 Degrees announces detection of babesia infection in 24% of patients in study
TipRanks · 12/29/2025 13:10
60 Degrees Pharmaceuticals Launches B-Free Study to Evaluate Tafenoquine for Chronic Babesiosis Fatigue
Reuters · 12/29/2025 13:01
60 DEGREES PHARMACEUTICALS ANNOUNCES DETECTION OF BABESIA INFECTION IN 24 PERCENT OF PATIENTS PRESENTING WITH CHRONIC FATIGUE IN PEER-REVIEWED, SPONSORED STUDY AT NC STATE
Reuters · 12/29/2025 13:01
Weekly Report: what happened at SXTP last week (1222-1226)?
Weekly Report · 12/29/2025 10:17
Here's Why 60 Degrees Pharmaceuticals Inc. (SXTP) Looks Ripe for Bottom Fishing
NASDAQ · 12/23/2025 14:55
Weekly Report: what happened at SXTP last week (1215-1219)?
Weekly Report · 12/22/2025 10:17
More
About SXTP
60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases. It is focused on using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The Company's pipeline under development covers development programs for vector-borne, fungal, and viral disease utilizing three of the Company’s products: new products that contain the ARAKODA regimen of Tafenoquine; new products that contain Tafenoquine, and Celgosivir. Its lead product, ARAKODA is used for malaria prevention in individuals 18 years and older. It is also conducting due diligence activities in relation to potential in-licensing of a product relevant to Lyme disease and an antimalarial combination partner for Tafenoquine for P. vivax malaria.

Webull offers 60 Degrees Pharmaceuticals Inc stock information, including NASDAQ: SXTP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SXTP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SXTP stock methods without spending real money on the virtual paper trading platform.